Metacrine to Present at 30th Annual ROTH Conference


Corporate and panel presentations as part of NASH program

San Diego, CA – Metacrine, Inc., an innovative biotechnology company focused on drug development, today announced that Ken Song, MD, President and CEO, will give a corporate presentation and participate in a NASH panel discussion at the 30th Annual ROTH Conference taking place at the Ritz-Carlton in Dana Point, CA. The corporate presentation will take place Monday, March 12, 2018 at 3:30 p.m. Pacific in Green Salon-3. The panel presentation “Not All Fruits are the Same, But What about FXR Agonists?” will take place earlier that same day at 10 a.m. Pacific in Green Salon-3. The presentation is part of a two-day panel program on the latest topics and developments in NASH/PBC drug development.

About Metacrine

Metacrine is a privately held biotechnology company headquartered in San Diego, CA. The company is focused on efficiently developing innovative drugs that materially benefit patients with metabolic disease.

Investor Inquiries
Westwicke Partners
Robert H. Uhl
Managing Director